Pregnancy and Contraception in Patients with Pulmonary Arterial Hypertension

[1]  K. Dimopoulos,et al.  Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? , 2008, European heart journal.

[2]  D. Bani.  Relaxin as a natural agent for vascular health , 2008, Vascular health and risk management.

[3]  D. Driscoll,et al.  Hysteroscopic sterilization in women with severe cardiac disease: experience at a tertiary center. , 2008, Mayo Clinic proceedings.

[4]  H. Akashi,et al.  Arginine vasopressin is an ideal drug after cardiac surgery for the management of low systemic vascular resistant hypotension concomitant with pulmonary hypertension. , 2007, Interactive cardiovascular and thoracic surgery.

[5]  L. Howard,et al.  Use of vasopressin after Caesarean section in idiopathic pulmonary arterial hypertension. , 2007, British journal of anaesthesia.

[6]  R. Oudiz,et al.  Serial Hemodynamics and Complications of Pregnancy in Severe Pulmonary Arterial Hypertension , 2007, Cardiology.

[7]  E. Desantis,et al.  Treatment of pulmonary arterial hypertension in pregnancy. , 2007, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[8]  H. Muir,et al.  Critical arrhythmia associated with pulmonary artery catheterization in a parturient with severe pulmonary hypertension , 2007, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[9]  J. Gris,et al.  Monitoring the effects and managing the side effects of anticoagulation during pregnancy. , 2006, Obstetrics and gynecology clinics of North America.

[10]  F. Spertini,et al.  Fondaparinux is a safe alternative in case of heparin intolerance during pregnancy. , 2006, Blood.

[11]  H. Jick,et al.  Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel , 2006, Journal of Family Planning and Reproductive Health Care.

[12]  P. Cordeiro,et al.  Acute resynchronization with inhaled iloprost in a pregnant woman with idiopathic pulmonary artery hypertension. , 2006, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[13]  N. Panay,et al.  Pregnancy and contraception in heart disease and pulmonary arterial hypertension , 2006, Journal of Family Planning and Reproductive Health Care.

[14]  J. Laffey,et al.  Sildenafil for pulmonary hypertension in pregnancy? , 2006, Anesthesiology.

[15]  D. Cabrol,et al.  Preterm Torsion of a Gravid Uterus Didelphys Horn of a Twin Pregnancy , 2005, Obstetrics and gynecology.

[16]  I. Greer,et al.  Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy. , 2005, Blood.

[17]  G. Mills,et al.  The use of iloprost in early pregnancy in patients with pulmonary arterial hypertension , 2005, European Respiratory Journal.

[18]  D. Benhamou,et al.  Severe Pulmonary Hypertension during Pregnancy: Mode of Delivery and Anesthetic Management of 15 Consecutive Cases , 2005, Anesthesiology.

[19]  M. Bowen,et al.  Eisenmenger's syndrome in a 27 week pregnancy--management with bosentan and sildenafil. , 2005, Irish medical journal.

[20]  C. Warnes.  Pregnancy and pulmonary hypertension. , 2004, International journal of cardiology.

[21]  E. Ginsburg,et al.  Use of assisted reproductive technologies and anesthesia in a patient with primary pulmonary hypertension. , 2004, Fertility and sterility.

[22]  A. Germain,et al.  Management of Eisenmenger Syndrome in Pregnancy With Sildenafil and l-arginine , 2004, Obstetrics and gynecology.

[23]  D. Bani,et al.  Relaxin potentiates the expression of inducible nitric oxide synthase by endothelial cells from human umbilical vein in in vitro culture. , 2004, Molecular human reproduction.

[24]  J. Shumway,et al.  Intravenous and Inhaled Epoprostenol for Primary Pulmonary Hypertension During Pregnancy and Delivery , 2004, Obstetrics and gynecology.

[25]  O. Sherwood.  Relaxin's physiological roles and other diverse actions. , 2004, Endocrine reviews.

[26]  Duggan Ab,et al.  Combined Spinal and Epidural Anaesthesia for Caesarean Section in a Parturient with Severe Primary Pulmonary Hypertension , 2003, Anaesthesia and intensive care.

[27]  V. McLaughlin,et al.  Successful management of pregnancy in a patient with eisenmenger syndrome with epoprostenol. , 2003, Chest.

[28]  D. Cher,et al.  Microinsert Nonincisional Hysteroscopic Sterilization , 2003, Obstetrics and gynecology.

[29]  C. Hoover,et al.  Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk, 6th Edition , 2003 .

[30]  R. Brant,et al.  A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. , 2003, The New England journal of medicine.

[31]  A. Hingorani,et al.  Endothelial Nitric Oxide Synthase Gene Polymorphism and Maternal Vascular Adaptation to Pregnancy , 2001, Hypertension.

[32]  B. Cairns,et al.  Inhaled Nitric Oxide for Primary Pulmonary Hypertension in Pregnancy , 2001, Obstetrics and gynecology.

[33]  L. Monnery,et al.  Primary pulmonary hypertension in pregnancy; a role for novel vasodilators. , 2001, British journal of anaesthesia.

[34]  T. Garite,et al.  A comparison of echocardiography and pulmonary artery catheterization for evaluation of pulmonary artery pressures in pregnant patients with suspected pulmonary hypertension. , 2001, American journal of obstetrics and gynecology.

[35]  G. Olson,et al.  Pregnancy and primary pulmonary hypertension : successful outcome with epoprostenol therapy. , 2001, Chest.

[36]  R. Aubry,et al.  Twin pregnancy in a woman on long-term epoprostenol therapy for primary pulmonary hypertension. A case report. , 2000, The Journal of reproductive medicine.

[37]  H. Jick,et al.  Risk of idiopathic venous thromboembolism in users of progestagens alone , 1999, The Lancet.

[38]  M. Dooris,et al.  Management of labor in Eisenmenger syndrome with inhaled nitric oxide. , 1999, American journal of obstetrics and gynecology.

[39]  T. Easterling,et al.  Pulmonary hypertension in pregnancy: treatment with pulmonary vasodilators. , 1999, Obstetrics and gynecology.

[40]  M. Landzberg,et al.  Inhaled nitric oxide therapy in pregnancy complicated by pulmonary hypertension. , 1999, American journal of obstetrics and gynecology.

[41]  S. Adibi,et al.  Hormonal regulation of oligopeptide transporter Pept-1 in a human intestinal cell line. , 1999, American journal of physiology. Cell physiology.

[42]  K. Sørensen,et al.  Normal pregnancy is associated with enhanced endothelium-dependent flow-mediated vasodilation. , 1999, American journal of physiology. Heart and circulatory physiology.

[43]  K.,et al.  Anaesthesia for caesarean section in the presence of severe primary pulmonary hypertension. , 1998, British journal of anaesthesia.

[44]  O. Hess,et al.  Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. , 1998, Journal of the American College of Cardiology.

[45]  P. Vallance,et al.  Nitric oxide-mediated vasodilation in human pregnancy. , 1997, The American journal of physiology.

[46]  F. García-Río,et al.  Regulation of breathing and perception of dyspnea in healthy pregnant women. , 1996, Chest.

[47]  R. Crapo.  Normal cardiopulmonary physiology during pregnancy. , 1996, Clinical obstetrics and gynecology.

[48]  Richard Graham Knowles,et al.  Induction of nitric oxide synthases early in pregnancy. , 1994, American journal of obstetrics and gynecology.

[49]  L. Rochelle,et al.  Identification of increased nitric oxide biosynthesis during pregnancy in rats , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[50]  S. Hunter,et al.  Adaptation of the maternal heart in pregnancy , 1992, British heart journal.

[51]  P. Keast,et al.  The Effects of Oxytocin on the Pulmonary and Systemic Circulation in Pregnant Ewes , 1992, Anaesthesia and intensive care.

[52]  W. Lee,et al.  Cardiorespiratory alterations during normal pregnancy. , 1991, Critical care clinics.

[53]  J. Pivarnik,et al.  Central hemodynamic assessment of normal term pregnancy , 1989 .

[54]  P. Brill-Edwards,et al.  Heparin therapy during pregnancy. Risks to the fetus and mother. , 1989, Archives of internal medicine.

[55]  Abdelwahab Omri,et al.  Low Molecular Weight Heparin Novo (LHN-1) Does Not Cross the Placenta During the Second Trimester of Pregnancy , 1989, Thrombosis and Haemostasis.

[56]  F Hytten,et al.  Blood Volume Changes in Normal Pregnancy , 1985, Clinics in haematology.

[57]  P. Barash,et al.  Catheter-induced pulmonary artery perforation. Mechanisms, management, and modifications. , 1981, The Journal of thoracic and cardiovascular surgery.

[58]  R. Stevenson,et al.  Hazards of oral anticoagulants during pregnancy. , 1980, JAMA.

[59]  L. Dunn,et al.  PRIMARY PULMONARY HYPERTENSION IN PREGNANCY. , 1964, Obstetrical & gynecological survey.

[60]  M. Hoeper,et al.  Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension. , 2007, American heart journal.

[61]  J. Harenberg.  Treatment of a woman with lupus and thromboembolism and cutaneous intolerance to heparins using fondaparinux during pregnancy. , 2007, Thrombosis research.

[62]  T. Albertson,et al.  Epoprostenol in Pregnant Patients with Secondary Pulmonary Hypertension , 2004, Treatments in respiratory medicine.

[63]  R. Gherman,et al.  Favorable response of Eisenmenger syndrome to inhaled nitric oxide during pregnancy. , 1999, American journal of obstetrics and gynecology.

[64]  R. Pauli,et al.  Maternal and fetal sequelae of anticoagulation during pregnancy. , 1980, The American journal of medicine.